Antipsychotic Medications in LTC Education Program Scheduled for September 12

The Virginia Health Care Association has scheduled Under the Microscope: Antipsychotic Medications in LTC for September 12, 2012 at the Holiday Inn Koger Conference Center in Richmond.

The Centers for Medicare & Medicaid (CMS) and the American Health Care Association (AHCA) have each released a Quality Initiative with the goal to reduce the off-label use of antipsychotics 15 percent by December 31, 2012.  Since a large number of the individuals in nursing and assisted living facilities are living with some type of dementia and exhibit challenging behaviors, antipsychotic medications, too often, are used in an effort to modify these behaviors.  This use is considered “off-label” by the FDA, which has issued a “black box” warning for use in elderly residents with dementia or dementia-related psychosis.  

A CMS national action plan to inform the public is already underway with nursing facility rates of antipsychotic drug usage now reported on the updated Nursing Home Compare website.  Facilities must be aware and be prepared for increased surveyor scrutiny of residents with dementia taking these drugs.  This program will center on the implications of the CMS Initiative to “Improve Behavioral Health and Reduce the Use of Antipsychotic Medications in Nursing Home Residents” and define the regulatory requirements for appropriate use and gradual dose reductions of antipsychotic medications.  Steps facilities can take to be prepared for increased scrutiny by state and federal agencies through the long term care survey process will be identified.

For more information and online registration click here.